Literature DB >> 27183901

Adult attention-deficit hyperactivity disorder: key conceptual issues.

Philip Asherson1, Jan Buitelaar2, Stephen V Faraone3, Luis A Rohde4.   

Abstract

For many years, attention-deficit hyperactivity disorder (ADHD) was thought to be a childhood-onset disorder that has a limited effect on adult psychopathology. However, the symptoms and impairments that define ADHD often affect the adult population, with similar responses to drugs such as methylphenidate, dexamphetamine, and atomoxetine, and psychosocial interventions, to those seen in children and adolescents. As a result, awareness of ADHD in adults has rapidly increased and new clinical practice has emerged across the world. Despite this progress, treatment of adult ADHD in Europe and many other regions of the world is not yet common practice, and diagnostic services are often unavailable or restricted to a few specialist centres. This situation is remarkable given the strong evidence base for safe and effective treatments. Here we address some of the key conceptual issues surrounding the diagnosis of ADHD relevant to practising health-care professionals working with adult populations. We conclude that ADHD should be recognised in the same way as other common adult mental health disorders, and that failure to recognise and treat ADHD is detrimental to the wellbeing of many patients seeking help for common mental health problems.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27183901     DOI: 10.1016/S2215-0366(16)30032-3

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN: 2215-0366            Impact factor:   27.083


  58 in total

1.  Sex and racial/ethnic differences in the association between childhood attention-deficit/hyperactivity disorder symptom subtypes and body mass index in the transition from adolescence to adulthood in the United States.

Authors:  Y Inoue; A G Howard; A Stickley; A Yazawa; P Gordon-Larsen
Journal:  Pediatr Obes       Date:  2019-01-10       Impact factor: 4.000

2.  Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Suicide Attempts.

Authors:  Zheng Chang; Patrick D Quinn; Lauren O'Reilly; Arvid Sjölander; Kwan Hur; Robert Gibbons; Henrik Larsson; Brian M D'Onofrio
Journal:  Biol Psychiatry       Date:  2019-12-13       Impact factor: 13.382

3.  Differential attentional control mechanisms by two distinct noradrenergic coeruleo-frontal cortical pathways.

Authors:  Andrea Bari; Sangyu Xu; Michele Pignatelli; Daigo Takeuchi; Jiesi Feng; Yulong Li; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-02       Impact factor: 11.205

4.  Association Between Medication Use for Attention-Deficit/Hyperactivity Disorder and Risk of Motor Vehicle Crashes.

Authors:  Zheng Chang; Patrick D Quinn; Kwan Hur; Robert D Gibbons; Arvid Sjölander; Henrik Larsson; Brian M D'Onofrio
Journal:  JAMA Psychiatry       Date:  2017-06-01       Impact factor: 21.596

5.  Refining Diagnostic Procedures for Adults With Symptoms of ADHD.

Authors:  Margaret H Sibley; Stefany Coxe; Brooke S G Molina
Journal:  Assessment       Date:  2016-11-19

6.  Maternal cell phone use during pregnancy and child behavioral problems in five birth cohorts.

Authors:  Laura Birks; Mònica Guxens; Eleni Papadopoulou; Jan Alexander; Ferran Ballester; Marisa Estarlich; Mara Gallastegi; Mina Ha; Margaretha Haugen; Anke Huss; Leeka Kheifets; Hyungryul Lim; Jørn Olsen; Loreto Santa-Marina; Madhuri Sudan; Roel Vermeulen; Tanja Vrijkotte; Elisabeth Cardis; Martine Vrijheid
Journal:  Environ Int       Date:  2017-04-07       Impact factor: 9.621

7.  Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder.

Authors:  Karen Curtin; Annette E Fleckenstein; Brooks R Keeshin; Deborah A Yurgelun-Todd; Perry F Renshaw; Ken R Smith; Glen R Hanson
Journal:  Neuropsychopharmacology       Date:  2018-09-12       Impact factor: 7.853

Review 8.  Treatment strategies for ADHD: an evidence-based guide to select optimal treatment.

Authors:  Arthur Caye; James M Swanson; David Coghill; Luis Augusto Rohde
Journal:  Mol Psychiatry       Date:  2018-06-28       Impact factor: 15.992

Review 9.  Life Span Studies of ADHD-Conceptual Challenges and Predictors of Persistence and Outcome.

Authors:  Arthur Caye; James Swanson; Anita Thapar; Margaret Sibley; Louise Arseneault; Lily Hechtman; L Eugene Arnold; Janni Niclasen; Terrie Moffitt; Luis Augusto Rohde
Journal:  Curr Psychiatry Rep       Date:  2016-12       Impact factor: 5.285

10.  ADHD symptoms map onto noise-driven structure-function decoupling between hub and peripheral brain regions.

Authors:  Luke J Hearne; Hsiang-Yuan Lin; Paula Sanz-Leon; Wen-Yih Isaac Tseng; Susan Shur-Fen Gau; James A Roberts; Luca Cocchi
Journal:  Mol Psychiatry       Date:  2019-10-31       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.